Barclays Raises LifeStance Health Price Target to $18 From $15
Barclays maintained its Overweight rating on LifeStance Health Group.
Related stories
Microsoft Restores Service After Widespread Outage
Microsoft said full service to its products was restored as of early Saturday, including processing undelivered emails.
M impact | EQUITY | Nov 14, 2026, 09:57 AM UTC
Microsoft Restores Services After Hourslong Global Outage
Microsoft said services were fully restored after an hourslong global outage.
M impact | EQUITY | Nov 14, 2026, 09:12 AM UTC
Rs.4K cr Ramayana movie VFX maker parent Prime Focus shares in focus after 14x profit jump in Q2; stock up 61% in a year
New Delhi, Nov. 14 -- Prime Focus Ltd, the parent company of visual effects and animation studio DNEG, is likely to remain in focus on Monday after announcing its September-quarter
L impact | EQUITY | Nov 14, 2026, 09:04 AM UTC
Microsoft Restores Service After Global Outage
Microsoft said its disruption to central cloud services is over.
M impact | EQUITY | Nov 14, 2026, 09:01 AM UTC
US Flights to Resume After Air Traffic Network Failure
US flights are set to resume after an air traffic network failure disrupted operations.
M impact | EQUITY | Nov 14, 2026, 08:06 AM UTC
UniCredit Raises $3.5 Billion
M impact | EQUITY | Nov 14, 2026, 08:03 AM UTC